Positive Outlook and Buy Rating for Candel Therapeutics by HC Wainwright Co Analyst
On November 13, 2023, Vernon Bernardino, an analyst at HC Wainwright & Co., reaffirmed his positive outlook on Candel Therapeutics ...
Tag: CADL
Candel Therapeutics Faces Quarterly Loss but Shows Promise in Cancer Treatment
On November 9, 2023, Candel Therapeutics (NASDAQ:CADL) experienced a disappointing quarterly loss of $(0.29) per share. This result fell short ...
Positive Results of CAN2409 Trial Spark Surge in Candel Therapeutics Inc Stock Trading
On November 6, 2023, Candel Therapeutics Inc (NASDAQ:CADL) announced significant findings from their ongoing phase 2 trial of CAN-2409 combined ...
Candel Therapeutics Unveils Groundbreaking Viral Immunotherapies for Solid Tumors
On November 6, 2023, Candel Therapeutics unveiled groundbreaking findings from its enLIGHTENâ„¢ Discovery Platform during the esteemed Society for Immunotherapy ...
Olezarsen A Promising Breakthrough in Treating High Triglyceride Levels
On September 26, 2023, Ionis Pharmaceuticals made an exciting announcement regarding their Phase 3 Balance study of olezarsen. This study ...
Promising Findings from Phase 2 Clinical Trial of CAN2409 in NonSmall Cell Lung Cancer and Other Cancers
Candel Therapeutics, a renowned pharmaceutical company, has recently announced promising findings from its Phase 2 clinical trial of CAN-2409 in ...
Insider Transactions and Their Significance
On June 30, 2023, Diem Nguyen, a member of the board at Candel Therapeutics, made a significant move by acquiring ...
Candel Therapeutics Reports Significant Losses and Negative ROCE Ratio
Candel Therapeutics, a company specializing in the development of innovative therapies, has recently reported its financial performance for Q2 and ...